Saturday, August 1 • 2:10pm - 3:40pm
Making the Case For Psychosocial Health in Cancer Care: Global Barriers and Opportunities

Sign up or log in to save this to your schedule and see who's attending!

The field of psychosocial oncology, with decades of research around improved clinical outcomes and increasing recognition as part of the standard of care, remains challenged to demonstrate its full impact in cancer care. What’s missing in our research, our practice and policies that will substantiate the value of psychosocial care? How can we better make the case for the integration of psychosocial care to healthcare providers and administrators, to patients and families, to payers and policymakers? What can we learn from other countries that we can apply in our own communities? Is there a universal need that we all share and can commit to as a global movement in quality cancer care? 

MODERATOR: Susan Dentzer is the senior policy adviser for the Robert Wood Johnson Foundation. She was the editor-in-chief of the journal Health Affairs. She is an elected member of the Institute of Medicine and the Council on Foreign Relations. She is a former health correspondent for the News Hour with Jim Lehrer and correspondent and columnist for U.S. News & World Report and Newsweek. 

(PSYCHIATRY) David Kissane, MD is an academic psychiatrist, psycho-oncology researcher and author. He is currently the Head of Psychiatry for Monash University in Australia, recently the Chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center in New York. His academic interests include group, couples and family psychotherapy trials, communication skills training, studies of existential distress, and the ethics of end-of-life care. He is best known for his model of family therapy delivered to ‘at risk’ families during palliative care, which prevents complicated grief and depression in bereavement. 

(PEDIATRICS/NETHERLANDS) Martha Grootenhuis, Ph.D is Head Research and Co-Director of the Pediatric Psychology Department of the Emma Children’s Hospital Amsterdam. Her research is on pediatric psychology (children with chronic diseases) and pediatric psychosocial oncology in particular. She is involved in the evaluation and implementation of innovative (ehealth) interventions for children and parents. In 2007 she founded the Pediatric Psycho-Oncology committee with SIOP (SIOP-PPO). 

(PSYCHOLOGY) Paul Jacobsen, PhD is currently the Associate Center Director for Population Science, Dr. Jacobsen was recruited to the Moffitt Cancer Center in Tampa Florida in 1994 to direct the Center’s clinical and research programs in psychosocial oncology. He was among the first investigators to describe how and why many patients continue to experience problems in quality of life long after they have completed cancer treatment.  He has also been a pioneer in developing and evaluating strategies, now widely disseminated, that patients can use to better deal with the stress of being diagnosed and treated for cancer. Recently, he has focused his efforts on increasing the availability of psychosocial care for people with cancer nationally and internationally through his work with the ASCO, IPOS and several other major professional organizations. 

(ONCOLOGY SOCIAL WORK/ADVOCACY) Vicki Kennedy, LCSW is Vice President, Program Development & Delivery for the Cancer Support Community (CSC) global organization in Washington, DC. An oncology social worker for the past 32 years, Ms. Kennedy is responsible for development, delivery and quality assurance of CSC community-based psychosocial programs worldwide.  Ms. Kennedy formerly served as Co-Founder/CEO of The Wellness Community-Central Indiana; psycho-oncology researcher at the Walther Cancer Institute in Indianapolis; and staff social worker of the IU Cancer Center in bone marrow transplant/hematology. She is a past-president of the Association of Oncology Social Work (AOSW) and an APOS board member. Ms. Kennedy is leading the dissemination of distress screening and treatment decision support counseling across CSC and cancer centers as well as participating in cost-effectiveness of psychosocial care research. 

(POLICY/HEALTH CARE) Clifford Goodman, PhD is a Senior Vice President at The Lewin Group, a health care policy and human services consulting firm located near Washington, D.C. He has 30 years of experience in health care evaluation, including HTA, evidence-based health care, comparative effectiveness research (CER), health economics, and studies pertaining to health care innovation, regulation and payment. He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology and medical device companies; health care provider institutions; and professional, industry and patient advocacy groups. His recent work has involved such areas as oncology, cardiovascular disease, diabetes, obesity, end-stage renal disease, biosimilars, and personalized medicine. He serves on the editorial boards of the International Journal of Technology Assessment in Health Care and the American Journal of Managed Care. 


This plenary is generously supported by the Cancer Support Community with a grant from Bristol-Myers Squibb.

Saturday August 1, 2015 2:10pm - 3:40pm
Liberty Ballroom Meeting Level 4

Attendees (0)